Challenges in improving influenza vaccine protection in the elderly.
about
Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvantAdvax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses.Pediatric influenza immunization
P2860
Challenges in improving influenza vaccine protection in the elderly.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Challenges in improving influenza vaccine protection in the elderly.
@en
Challenges in improving influenza vaccine protection in the elderly.
@nl
type
label
Challenges in improving influenza vaccine protection in the elderly.
@en
Challenges in improving influenza vaccine protection in the elderly.
@nl
prefLabel
Challenges in improving influenza vaccine protection in the elderly.
@en
Challenges in improving influenza vaccine protection in the elderly.
@nl
P2860
P356
P1476
Challenges in improving influenza vaccine protection in the elderly.
@en
P2093
Ted M Ross
P2860
P356
10.1586/ERV.10.153
P577
2011-01-01T00:00:00Z